Week 120 Efficacy of Tenofovir, Lamivudine and Lopinavir/r-Based Second-Line Antiretroviral Therapy in Treatment-Experienced HIV Patients

BACKGROUND: Tenofovir (TDF) and ritonavir-boosted lopinavir (LPV/r) were not introduced to China as second-line medications until 2009. The efficacy and safety of TDF/3TC/LPV/r based second-line regimen have not been evaluated in Chinese HIV patients who failed first-line regimens. METHODS: This was...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yang, Li, Yijia, Xie, Jing, Qiu, Zhifeng, Li, Yanling, Song, Xiaojing, Zhu, Ting, Li, Taisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379083/
https://www.ncbi.nlm.nih.gov/pubmed/25821963
http://dx.doi.org/10.1371/journal.pone.0120705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379083/
https://www.ncbi.nlm.nih.gov/pubmed/25821963
http://dx.doi.org/10.1371/journal.pone.0120705

Ejemplares similares